Work

Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine–naloxone and standard medical management?

Year: 2014

Type: article

Source: Drug and Alcohol Dependence

DOI: 10.1016/j.drugalcdep.2014.04.005

Authors: Roger D. Weiss, Margaret L. Griffin, Jennifer Sharpe Potter, Dorian R. Dodd, Jessica A. Dreifuss, Hilary S. Connery, Kathleen M. Carroll

Institutions: Harvard University, McLean Hospital, The University of Texas at San Antonio Health Science Center, Yale University

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute on Drug Abuse

Awards: Clinical Trials Network: The Texas Node, Mentoring in drug abuse and dual diagnosis research, The National Drug Abuse Treatment Clinical Trials Network (U10), Treatment of Opioid Dependence and Chronic Pain, NIDA Clinical Trials Network: Big South/West Node

OpenAlex ID: W2018310109

FWCI: 4.623

Cites: 43

Cited by: 44

Related to: 10